HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

A 192621

ET(B) receptor antagonist
Also Known As:
(2R-(2alpha,3beta,4alpha)-4-(1,3-benzodioxol-5-yl)-1-(2-(2,6-diethylphenyl)amino)-2-oxoethyl)-2-(4-propoxyphenyl)-3-pyrrolidinecarboxylic acid; A-192621; A192621
Networked: 32 relevant articles (5 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Matsumura, Yasuo: 5 articles (12/2009 - 09/2002)
2. Rae, Giles Alexander: 4 articles (06/2010 - 06/2006)
3. Takaoka, Masanori: 4 articles (01/2005 - 09/2002)
4. Chichorro, Juliana Geremias: 3 articles (06/2010 - 06/2006)
5. Rae, Giles A: 2 articles (05/2009 - 04/2009)
6. D'Orléans-Juste, Pedro: 2 articles (05/2009 - 06/2006)
7. Chichorro, Juliana G: 2 articles (05/2009 - 04/2009)
8. Zampronio, Aleksander Roberto: 2 articles (07/2006 - 06/2006)
9. Matsumoto, Noriko: 2 articles (01/2005 - 11/2004)
10. Gariepy, Cheryl E: 2 articles (01/2005 - 09/2002)

Related Diseases

1. Pulmonary Hypertension (Ayerza Syndrome)
2. Heart Failure
3. Melanoma (Melanoma, Malignant)
4. Ischemia
5. Neoplasms (Cancer)

Related Drugs and Biologics

1. A 127722
2. Sodium
3. Oxygen
4. SB 247083
5. PD 155080
6. Endothelin-1 (Endothelin 1)
7. salicylhydroxamic acid (SHAM)
8. atrasentan
9. Endothelins (Endothelin)
10. cyclo(Trp-Asp-Pro-Val-Leu)

Related Therapies and Procedures

1. Oral Administration
2. Injections